BioAxone is developing a broad pipeline of therapeutic drugs to treat unmet needs in neurotrauma and neurovascular disorders.

  • Orally-available small molecules to treat Cavernous angioma
  • Therapies directed at new targets to treat spinal cord injury
  • Oral or IV formulations to treat stroke
  • Combination therapies to address the needs of chronic spinal cord injury